CHORD Therapeutics

Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases.

[CHORD Therapeutics @CHORDtx]

Merck KGaA snatches up Geneva biotech as repurposed chemotherapy mission strikes a 'Chord'
https://t.co/VAl2p4b8k1

[CHORD Therapeutics @CHORDtx]

Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics

https://t.co/VB4pBOjoDB

[CHORD Therapeutics @CHORDtx]

https://t.co/VB4pBOjoDB

[CHORD Therapeutics @CHORDtx]

Founder Arthur Roach and CEO Tom Plitz introduce Chord Therapeutics’ mission to bring new oral treatments to patients with rare diseases, building on $16 million investment by Omega Funds.
#NMOSD #rarediseases
https://t.co/O8W5V3vfm1

[CHORD Therapeutics @CHORDtx]

We are delighted to announce that we have closed a $16 million Series A financing from Omega Funds. This funding will enable us to progress our development programs for #NMOSD and #myasthenia into the clinic.
#rarediseases #autoimmune #blindness #CNS
https://t.co/jkHHxytLu0